Dengue virus vaccine (adenoviral vector) (GenPhar)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameDengue virus vaccine (adenoviral vector) (GenPhar)
Drug Alias NamecAdVax-Dengue
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenphar
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenphar
Active IndicationsN/A
Inactive IndicationsDengue

Other Information

ATC CodeN/A
Related LinksN/A